Durvalumab, Cediranib ± Olaparib in Recurrent Ovarian Cancer
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
In the relentless pursuit of more effective cancer immunotherapies, scientists have long been challenged by the complexity of harnessing the ...
A revolutionary approach to cancer treatment is currently being developed by a dedicated research team led by the University of ...
In a groundbreaking study published in Medical Oncology, researchers have unveiled the promising therapeutic potential of bone marrow-derived mesenchymal stem ...
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
In a remarkable leap forward for cancer therapeutics, researchers at UCLA, in collaboration with an international scientific team, have unveiled ...
In a groundbreaking advancement within the realm of cancer immunotherapy, researchers have developed an innovative bacterial-based treatment known as ACTM-838, ...
Scientists at the University of Cambridge have unveiled a groundbreaking approach to cancer immunotherapy that promises to drastically enhance both ...
In the quest to develop cancer therapies that minimize harm to healthy tissues, a groundbreaking approach employing ultrasound to chemically ...
A groundbreaking advance in molecular imaging has emerged that promises to transform the diagnosis and management of triple-negative breast cancer ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine